Flu Vaccination After Coronary Artery Bypass Surgery

Evidence Supporting Vaccination

The American Heart Association recommends influenza vaccination for post-bypass patients, as it significantly reduces cardiovascular events and mortality in high-risk cardiac patients 1, 2, 3
A meta-analysis of 6 randomized trials involving 6,735 high-risk cardiovascular patients demonstrated that influenza vaccine significantly lowered cardiovascular events (RR 0.64; 95% CI 0.48-0.86; P=0.003), with the greatest benefit in patients with more active coronary artery disease 1, 2, 3
Influenza infection can trigger acute thrombotic events by promoting rupture of vulnerable atherosclerotic plaques, causing fluid overload and heart failure, or affecting already vulnerable patients 1, 2
Seasonal influenza-like illnesses have been linked to the timing of acute myocardial infarction and other cardiovascular events 1, 2
Influenza vaccination reduces hospitalizations for cardiac disease and stroke among elderly patients 1, 2
The benefits of preventing potentially fatal cardiovascular complications from influenza far outweigh any theoretical concerns about perioperative vaccination 1, 2, 3

The American Heart Association's scientific statement on secondary prevention after CABG explicitly supports influenza vaccination for post-bypass patients 1, 2, 3

Do not delay vaccination unnecessarily if flu season has begun—the risk of influenza infection in an unvaccinated post-CABG patient is substantial 1, 2
Do not assume vaccination eliminates all risk—while protective, breakthrough infections can still occur, so other preventive measures remain important 1, 2